GC
MJN

Guggenheim Capital’s Mead Johnson Nutrition Company MJN Stock Holding History

Guggenheim Capital’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-583,513
Closed -$52M – 2913
2017
Q1 		$52M Sell
583,513
-12,074
-2% -$993K 0.14% 248
2016
Q4 		$42.1M Sell
595,587
-5,740
-1% -$428K 0.12% 335
2016
Q3 		$47.5M Buy
601,327
+1,291
+0.2% +$110K 0.15% 189
2016
Q2 		$54.5M Sell
600,036
-804
-0.1% -$68.1K 0.17% 139
2016
Q1 		$51.1M Buy
600,840
+86,421
+17% +$6.43M 0.16% 151
2015
Q4 		$40.6M Buy
514,419
+25,170
+5% +$1.98M 0.12% 269
2015
Q3 		$34.4M Buy
489,249
+8,451
+2% +$695K 0.11% 325
2015
Q2 		$43.4M Buy
480,798
+22,591
+5% +$2.18M 0.11% 311
2015
Q1 		$46.1M Buy
458,207
+75,164
+20% +$7.58M 0.11% 303
2014
Q4 		$38.5M Buy
383,043
+50,318
+15% +$5.02M 0.1% 375
2014
Q3 		$32M Sell
332,725
-51,087
-13% -$4.84M 0.08% 451
2014
Q2 		$35.8M Buy
383,812
+89,364
+30% +$7.81M 0.09% 368
2014
Q1 		$24.5M Buy
294,448
+30,333
+11% +$2.46M 0.07% 512
2013
Q4 		$22.1M Buy
264,115
+14,600
+6% +$1.19M 0.07% 525
2013
Q3 		$18.5M Buy
249,515
+62,200
+33% +$4.66M 0.07% 497
2013
Q2 		$14.8M Buy
+187,315
New +$15M 0.06% 531

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Guggenheim Capital's MJN Position: Q2 2017 in Review

Guggenheim Capital sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 583,513 shares — an estimated $52M sold.

Guggenheim Capital first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $54.5M in Q2 2016. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Guggenheim Capital reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Guggenheim Capital sold 583,513 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $52M.
  • Guggenheim Capital first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
  • Guggenheim Capital's Mead Johnson Nutrition Company position peaked at $54.5M in Q2 2016.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Guggenheim Capital's 13F filing for Q2 2017, filed 14 Aug 2017.